60 reports of this reaction
4.5% of all AMINOCAPROIC ACID reports
#2 most reported adverse reaction
OFF LABEL USE is the #2 most commonly reported adverse reaction for AMINOCAPROIC ACID, manufactured by American Regent, Inc.. There are 60 FDA adverse event reports linking AMINOCAPROIC ACID to OFF LABEL USE. This represents approximately 4.5% of all 1,338 adverse event reports for this drug.
Patients taking AMINOCAPROIC ACID who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among AMINOCAPROIC ACID users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for AMINOCAPROIC ACID:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 60 FDA reports for AMINOCAPROIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 4.5% of all adverse event reports for AMINOCAPROIC ACID, making it one of the most commonly reported side effect.
If you experience off label use while taking AMINOCAPROIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.